Charmed, you have distorted my message and intentions beyond my recognition so I will suffice it to leave it alone with you. I cannot argue points you are making when they do not represent what I think. Good luck
Charmed, On one further note. INCY is the top 10 holding of Orbimed. They knew David Hastings very well for years. Is it reasonable to presume that he was handpicked to come to UNIS, another company for which Orbimed is heavily invested in.
Charmed, I don't state any kind of conspiracy, nor do I think the scenarios I presented are ridiculous. I have put out a discussion about strategy. Money always has a trail, and just logically trying to follow it. Obviously, the fund purchased the shares for someone to hold or for someone to cover. They Cayman Fund cannot hold it all for themselves, nor can they use if for shorting activities, (ie loaning their shares for the purpose of shorting). So there are obviously other purposes for the use of the extra shares they got via trigger events. What is that purpose? You think they are just selling it to the open market? Then that is your thesis.
You seem to take offense with my ideas but have not presented your own. You basically think it is as simple as the Cayman Fund being an opportunist that took advantage of their deal to get more shares for the only purpose of making money just for themselves.
Let's be clear. Everyone in the circle of this deal is making money. It is not just the Cayman Fund.
FWIW, I calculated the net result of the Cayman Con Fund. I still don't know the purpose of this Fund. Was it to help Tilson cover his short position or was it to buy shares for Amgen on the open market?; I am not convinced that UNIS was conned, but that it could have been in the plan all along. Orbimed's Royalty affiliate to which UNIS pays royalties is based in the Cayman Islands. It doesn't seem to be coincidence that this Discover Fund is also based in the Cayman Islands. It wouldn't be a surprise if Orbimed had a hand in this. Our CFO is not stupid and I still believe that he was handpicked by Orbrimed to come to Unilife to lead them forward in the commericialization phase. Hastings did not leave INCY as a billion dollar business that he hatched from its infancy to come to Unilife on a whim. He was chosen IMO. In any event, however this seeming toxic financing transpired, I believe it was deemed essential and that it will not negatively impact UNIS in following through on an implementation strategy that will benefit execs and investors for the long term.
My calculation shows that the shares were acquired for .55/share. That is what I bought a large tranche at and am already up 100% on it so I feel like patting my back for being able to follow the money trail. The fact that this whole transaction was finalized and closed as indicated in yesterday's filing indicates to me that a deal with Amgen is finalized or very close and all loose ends are being tied to move forward.
Let me know if anyone comes up with a different calculation:
27,846,890=Total Shares Issued to Cayman Fund based on 2/3/2016 8K
7,900,000= Total Shares that should have been issued based on 790 preferred shares
19,946,890 = Additional Toxic shares issued due to trigger events
$7,900,000= $1 x 7.9M shares which is the conversion price
$7,500,000= Cash received for preferred shares
$15,400,000 Total cash received / 27.8M shares = .55/share
Itsa, you wrote " They hired talented people, developed impressive number of patents and more to be approved soon" which resonated with why I am here. When I spoke with Ramin re: the strength of their patents, he informed me that each time Big Pharma enters into a long term contract, they due excessive due diligence that includes ascertaining that their patents are valid. I also liked the fact that Orbimed ALSO reviewed the value of deals, operational capabilities and patents with 3rd party validation. There is a very good youtube video of Alan talking about the Orbimed DD . The video is called Unilife CEO: OrbiMed Deal Only the Beginning if you want to google and watch it.
This is a no brainer to be invested here. SEVERAL Big Pharma are lined up to get these most revolutionary devices for their pipeline. I believe Unilife is the future leader in this disruptive market for biologics because the biologic leaders are negotiating deals as we wait. My main concern was how solid the patents were and I know know that the validity has been substantiated by Sanofi, Astra Zeneca, Amgen, Hikma and Novartis and AbbVie (soon to lock in an agreement) as well as Orbimed. We have 7+ independent sources look under the hood and they have validated that this is the real deal. That is good enough for me to invest with conviction and confidence.
Charmed, your post is not conducive to sharing DD. My DD is not "designed to fool newbies" as you write. I post facts and my own opinions. You stated your one-sided facts...Frontier sold out. I noticed last quarter they Frontier sold 3M shares (before that they had 8.8M shares)That is a fact. The other side is that Camber Capital management started a new position at 2.8M shares. That is a fact. One fund sold and another bought or didn't. Last quarter I saw BlacRock and Vanguard and JPM increase postions. This meant more to me than Frontier selling shares. We now have to see who bought the rest of the Frontier shares LAST QTR. I would not be surprised if funds wanted to take capital losses as the price of UNIS was in the toilet with a SP of .50 at 12/31/2015. They have to wait 30 days to re-establish their positions IF they want back in.
Stop fooling everyone by making me out to be some kind of malicous poster with ulterior motives to fool people. I am a long term investor and poster and will be here for at least 5 years if Unilife is successful in execution. How long will you be here? It's best they you not antagonize investors if you are one yourself. But from your note that you want to "be making bank" I can sense that you have a short term trader mentality.
Charmed, the "shares held by funds" is down because not all the data is accounted for as of 12/31/2015. We will find out in the next 2 weeks as data come rolling in.
Last quarter Frontier was able to sell millions of their shares to other funds wanting significant sized positions. I suspect the same happened this quarter.
Chuck, I am certainly doing my part buying some more shares under a dollar. Still can't believe it is sitting at this price just waiting.
Thanks Itsa. I did see taisan12's post but I am not a member so I could not see the attachment when I clicked on it. Is there anyway to cut and paste it here? What was it about?
Are you talking about a share count report? I do not recall seeing anything about Amgen. If you can direct me to a link I would appreciate it.
However, it is more likely the Cayman con fund is the source of shares for crying shorts that cannot cover their positions fast enough
unless the Caymen con fund is accumulating shares for Amgen. Then this is not the worst deal, but the best one for Amgen and Unilife in the long run
So glad to see you doing the same commentary for Idera as you did for Avanir! Hope it is a sign of long term good luck to find you here. This time I am more heavily invested here than I was with AVNR so hoping to make a lot more down the road. GL to us all and keep posting!
There was some mention of it here in a white paper written in 2012:
VirnetX entered into a letter of intent with VeriSign, a domain and internet security certificate
provider, on December 23, 2009. The two companies initiated a partnership to explore the
development of mobile directory services and solutions. This marked the first public release of
information suggesting VirnetX was collaborating with a commercial system integrator for the
advancement of its secure domain names technology. Subsequent information from the company
regarding partnerships and collaborative projects has been limited. The silence may be a result of
continuous litigation activities as well as strategic policy. VeriSign announced the sale of its
Authentication Services1 business to Symantec Corp. on May 19, 2010. The transaction closed on
August 9, 2010 for approximately $1.28 billion.
This is from the Gabriel website, so surely Virnetx can develop a standard for emails:
Send & receive secure encrypted email with attachments directly from sender to recipient without requiring a centralized mail server! No cyber threats! And best of all... NO SPAM!
This project will result in one or more demonstration prototype DNS-based secure email platforms, a publicly available NIST Cybersecurity Practice Guide that explains how to employ the platform(s) to meet security and privacy requirements, and platform documentation necessary to compose a DNS-based email security platform from off the shelf components.
A Notice by the National Institute of Standards and Technology on 10/06/2015
Previous DocumentNext Document
PDF DEV PRINT PUBLIC INSPECTION
This project sounds directly related to Virnetx patented technology. Does anyone with strong tech background care to provide more insight.? To me it reads like the government is FINALLY digging in and getting things done. The domain name initiative was announced by Virnetx 6 years ago. We may be at the tipping point where it will be implemented in the next 2 years as I am beginning to see some actions taken in this direction.
Tuesday, October 06, 2015
Department of Commerce
National Institute of Standards and Technology
Interested parties must contact NIST to request a letter of interest template to be completed and submitted to NIST that identifies the organization requesting participation in the Domain Name System- Based Security for Electronic Mail Building Block and the capabilities and components that are being offered to the collaborative effort. Letters of interest will be accepted on a first come, first served basis. Collaborative activities will commence as soon as enough
The National Institute of Standards and Technology (NIST) invites organizations to provide products and technical expertise to support and demonstrate security platforms for the Domain Name System-Based (DNS) Security for Electronic Mail Building Block. This notice is the initial step for the National Cybersecurity Center of Excellence (NCCoE) in collaborating with technology companies to address cybersecurity challenges identified under the Domain Name System-Based Security for Electronic Mail Building Block. Participation in this building block is open to all interested organizations.
I noted that VHC was not on the list, however, Microsoft is on the list and they have a paid up license to Virnetx technology. Also, sine the CEO fireside chae in 9/2014. we have not heard anything about the secure domain name initiative which is supposed to be the lucrative business going forward. I have always expected that Microsoft would be the partner to get that in motion thus generating royalties to Virnetx.
IPVALUE is also working in the background securing license agreements. It is my belief that nothing will come of this until we clear the Apple trial once and for all. This case is knowledge to all of the potential licensees who are not going to pay one penny until the trial rules. It is already certain that Apple will pay, just how much. All eyes want to see before they have to pay themselves IMO.